BPC-157 10mg

• Demonstrates strong tissue-healing and cytoprotective effects in numerous animal (mainly rodent) studies across multiple organ systems.
• In tendon fibroblasts (rat Achilles tendon model) BPC-157 up regulated the growth hormone receptor (GHR) at both mRNA and protein levels, increasing the cells’ responsiveness to growth hormone, and activated downstream JAK2 signalling.
• Exhibits angiogenic / pro-blood-flow effects, meaning it promotes new blood vessel formation in injured/ischemic tissue, which supports nutrient/oxygen delivery and healing.
• Modulates the nitric oxide (NO) system and appears to stabilize endothelial or vascular integrity (e.g., in alcohol- or ischemia-induced vascular damage in animal models).
• Demonstrates broad protective effects beyond musculoskeletal tissue: e.g., wound healing in skin, protection against arterial/venous thrombosis in animal models, protection of neural tissue (brain, spinal cord) in injury models.
• In orthopaedic sports-medicine review: animal studies show improved outcomes in muscle, tendon, ligament, bone injuries; one small retrospective human report (12 of 16 subjects) with knee injection of BPC-157 reported improvement of chronic knee pain >6 months.
• Key mechanism pathways implicated: fibroblast activation/collagen synthesis, FAK-paxillin signalling (cell migration/attachment), GHR/JAK2 axis, angiogenesis, endothelial protection, NO modulation.
• Animal studies show BPC-157 accelerates healing of soft tissues (muscle, tendon, ligament, bone) which indirectly may reduce pain by speeding repair and reducing ongoing nociceptive input.
• Improvements in pain, joint swelling and recovery time maybe observed due to it’s anti-inflammatory effects.

Links to studies: https://pubmed.ncbi.nlm.nih.gov/?term=BPC-157